Quick turnaround NGS assay for the characterization of biomarkers in FFPE tissue

Genomic profiling of a tumor to characterize clinically relevant variants has become critically important for cancer diagnosis and prognosis, as well as in driving therapeutic decision making. This analytical validation addresses The Oncomine™ Precision Assay’s detection of hotspot mutations (substitutions, insertions, deletions, copy number variations [CNVs], and fusions) in FFPE tissue. Download this poster to explore the methods, results, and conclusions of this study.


Complete the form below to access this scientific poster.